| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |